Antithymocyte Globulin (ATG)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Antithymocyte Globulin (ATG), covering 2016-10-25 to 2025-09-25. Get the full timeline:
Most recent: Clinical Trial Update: STOP-T1D Low-Dose (ATG) [Phase 2]